Cargando…

Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas

BACKGROUND: The aim of the study was to assess the localization of Polysialic acid (polySia) and Neural cell adhesion molecule (NCAM) in grade I–IV astrocytomas by confocal microscopy, and also to clarify and compare their relationship to conventional clinicopathological features in these tumors. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mäkelä, Katri, Nordfors, Kristiina, Finne, Jukka, Jokilammi, Anne, Paavonen, Timo, Haapasalo, Hannu, Korja, Miikka, Haapasalo, Joonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161890/ https://www.ncbi.nlm.nih.gov/pubmed/25164322 http://dx.doi.org/10.1186/1471-2407-14-623

Ejemplares similares

Complement activation in astrocytomas: deposition of C4d and patient outcome
por: Mäkelä, Katri, et al.
Publicado: (2012)

Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma
por: Korja, Miikka, et al.
Publicado: (2009)

The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
por: Haapasalo, Joonas, et al.
Publicado: (2020)

The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis
por: Nordfors, Kristiina, et al.
Publicado: (2010)

Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry
por: Haapala, Ilkka, et al.
Publicado: (2022)

Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Erratum: Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma
por: Nordfors, Kristiina, et al.
Publicado: (2018)

Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas
por: Valkonen, Mari, et al.
Publicado: (2018)

Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors
por: Karjalainen, Sini L., et al.
Publicado: (2018)

Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
por: Rautajoki, Kirsi J., et al.
Publicado: (2023)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)

Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells
por: Lehti, Timo A., et al.
Publicado: (2017)

Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication
por: Wolf, Maija, et al.
Publicado: (2010)

Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells
por: Skog, Maria S., et al.
Publicado: (2016)

MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells
por: Phoa, Athena F., et al.
Publicado: (2020)

MPC-07 MECHANISMS OF BETTER PROGNOSIS IN IDH-MUTATED ASTROCYTOMA WITH 19Q-LOSS
por: Otani, Ryohei, et al.
Publicado: (2019)

Expression of iron-related genes in human brain and brain tumors
por: Hänninen, Milla M, et al.
Publicado: (2009)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Similarities between the responses to ANT‐DBS and prior VNS in refractory epilepsy
por: Kulju, Toni, et al.
Publicado: (2018)

IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis
por: Otani, Ryohei, et al.
Publicado: (2018)

Peritumoral T2/FLAIR hyperintense MRI findings of meningiomas are not necessarily edema and may persist permanently: a systematic review
por: Laajava, Joonas, et al.
Publicado: (2023)

Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
por: Yang, Xiefeng, et al.
Publicado: (2022)

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.
por: Haapasalo, H., et al.
Publicado: (1996)

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience
por: Cho, Uiju, et al.
Publicado: (2021)

Rare Cases of IDH1 Mutations in Spinal Cord Astrocytomas
por: Konovalov, N. A., et al.
Publicado: (2020)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Polysialic Acid in the Immune System
por: Villanueva-Cabello, Tania M., et al.
Publicado: (2022)

Neuroimmunomodulatory properties of polysialic acid
por: Gretenkort, Lina, et al.
Publicado: (2023)

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma
por: Sabunga, Olivia Desty, et al.
Publicado: (2022)

LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
por: da Silva, Roseli, et al.
Publicado: (2015)

High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas
por: Huse, Jason T., et al.
Publicado: (2011)

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020)

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma
por: Auer, Timo Alexander, et al.
Publicado: (2021)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
por: Christians, Arne, et al.
Publicado: (2019)

Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas
por: Liu, Yan, et al.
Publicado: (2022)

LGG-45. A REPORT OF IDH-MUTANT BRAINSTEM ASTROCYTOMAS IN YOUNG ADULTS
por: Chang, Ellen, et al.
Publicado: (2020)

The prognostic impact of subclonal IDH1 mutation in grade 2–4 astrocytomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
por: Kibe, Yuji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s7k2v74j0ai52s8a4klshvj7ha